Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Omeros Corp (OMER)  
$3.15 0.09 (2.94%) as of 4:30 Fri 4/26


Download
   
Exchange: Nasdaq Small Cap
Security Type: Common
Shares Out: 61,650,000
Market Cap: 194.20(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.08 - $7.57
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    : 6.1
Insider 3/6 Months : 6.7
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Omeros is a commercial-stage biopharmaceutical company. Co. is focused on discovering, developing and commercializing small-molecule and protein therapeutics for larger-market as well as orphan indications targeting immunologic diseases. Co.'s drug candidate narsoplimab is the subject of a biologics license application pending before the U.S. Food and Drug Administration for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy. Co. has various late-stage clinical development programs in its pipeline, which are focused on: complement-mediated disorders, including immunoglobulin A nephropathy, atypical hemolytic uremic syndrome and COVID-19.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 25,000 25,000 25,000
Total Buy Value $0 $40,500 $40,500 $40,500
Total People Bought 0 2 2 2
Total Buy Transactions 0 2 2 2
Total Shares Sold 0 0 10,000 10,000
Total Sell Value $0 $0 $64,950 $64,950
Total People Sold 0 0 2 2
Total Sell Transactions 0 0 2 2
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 125
  Page 5 of 5  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Kelbon Marcia S. VP Patent and General Counsel   •       –      –    2016-04-15 4 AS $15.18 $241,392 D/D (15,900) 163,597     -
   Kelbon Marcia S. VP Patent and General Counsel   •       –      –    2016-04-15 4 OE $0.98 $15,582 D/D 15,900 179,497     -
   Cable Thomas J. Director   –       •      –    2016-03-24 4 AS $14.71 $29,627 D/D (2,000) 49,067     -
   Kelbon Marcia S. VP Patent and General Counsel   •       –      –    2016-03-23 4 OE $4.10 $62,201 D/D 15,171 163,597     -
   Kelbon Marcia S. VP Patent and General Counsel   •       –      –    2016-03-15 4 AS $15.12 $240,414 D/D (15,900) 148,426     -
   Kelbon Marcia S. VP Patent and General Counsel   •       –      –    2016-03-15 4 OE $0.98 $15,582 D/D 15,900 164,326     -
   Kelbon Marcia S. VP Patent and General Counsel   •       –      –    2016-03-08 4 AS $15.03 $478,005 D/D (31,800) 148,426     -
   Kelbon Marcia S. VP Patent and General Counsel   •       –      –    2016-03-08 4 OE $0.98 $31,164 D/D 31,800 180,226     -
   Demopulos Gregory A Md Chairman, CEO & President   •       •      –    2016-01-14 4 OE $0.98 $98,000 D/D 100,000 1,703,822     -
   Kelbon Marcia S. VP Patent and General Counsel   •       –      –    2016-01-14 4 OE $4.10 $41,000 D/D 10,000 148,426     -
   Kelbon Marcia S. VP Patent and General Counsel   •       –      –    2015-11-23 4 AS $15.00 $238,500 D/D (15,900) 131,126     -
   Kelbon Marcia S. VP Patent and General Counsel   •       –      –    2015-11-23 4 OE $0.98 $15,582 D/D 15,900 147,026     -
   Cable Thomas J. Director   –       •      –    2015-11-18 4 AS $13.73 $27,469 D/D (2,000) 51,067     -
   Demopulos Peter A Md Director   –       •      –    2015-09-04 4 B $12.68 $50,238 D/D 3,962 185,182 2.39     -
   Demopulos Gregory A Md Chairman, CEO & President   •       •       •   2015-08-18 4 OE $0.98 $11,760 D/D 12,000 1,603,822     -
   Cable Thomas J. Director   –       •      –    2015-07-15 4 AS $18.78 $37,556 D/D (2,000) 53,067     -
   Kelbon Marcia S. VP Patent and General Counsel   •       –      –    2015-07-07 4 OE $2.45 $12,500 D/D 5,102 131,126     -
   Cable Thomas J. Director   –       •      –    2015-03-24 4 AS $24.43 $48,991 D/D (2,000) 55,067     -
   Demopulos Gregory A Md Chairman, CEO & President   •       •       •   2015-01-28 4 OE $0.98 $31,360 D/D 32,000 1,591,822     -
   Demopulos Gregory A Md Chairman, CEO & President   •       •      –    2014-11-02 4 OE $0.98 $32,340 D/D 33,000 1,559,822     -
   Cable Thomas J. Director   –       •      –    2014-09-02 4 AS $15.07 $75,330 D/D (5,000) 57,067     -
   Demopulos Peter A Md Director   –       •      –    2014-06-24 4 B $16.20 $99,704 D/D 6,153 181,220 2.39     -
   Cable Thomas J. Director   –       •      –    2014-06-02 4 AS $11.79 $59,004 D/D (5,000) 62,067     -
   Demopulos Gregory A Md Chairman, CEO & President   •       •      –    2014-05-18 4 OE $0.98 $19,600 D/D 20,000 1,526,822     -
   Kelbon Marcia S. VP Patent and General Counsel   •       –      –    2014-05-16 4 OE $0.98 $3,699 D/D 3,774 126,024     -
  125 Records found
  1  2  3  4  5    
  Page 5 of 5
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us